Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for BioCorRx (BICX) over the last 12 years, with Q3 2025 value amounting to $18.2 million.

  • BioCorRx's Shares Outstanding (Diluted Average) rose 6650.44% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 6650.44%. This contributed to the annual value of $176.6 million for FY2010, which is N/A changed from last year.
  • Per BioCorRx's latest filing, its Shares Outstanding (Diluted Average) stood at $18.2 million for Q3 2025, which was up 6650.44% from $10.9 million recorded in Q3 2024.
  • Over the past 5 years, BioCorRx's Shares Outstanding (Diluted Average) peaked at $18.2 million during Q3 2025, and registered a low of $10.9 million during Q3 2024.